DRAP allows import, manufacturing of Remdesivir


ISLAMABAD: Drug Regulatory Authority of Pakistan (DRAP) has issued registration letters for import and manufacturing of Remdesivir used for critically ill patients of COVID-19.

According to spokesman Ministry of National Health Services, on increasing demand, approvals are issued to two importers and 14 local manufacturers.

He said Remdesivir is approved for emergency use in a special emergency meeting in order to ensure early availability.

You May Also Like


Elections for 24 seats of GB Assembly to be held on 18th of next month

GILGIT: Elections for 24 seats of Gilgit Baltistan Assembly


KP Govt allocates Rs33b in budget to cope with locust swarms

PESHWAR: Khyber Pakhtunkhwa Minister for Agriculture Mohibullah


Promotion of religious harmony in Punjab Govt’s top priority: Buzdar

LAHORE: Punjab Chief Minister Sardar Usman Buzdar says promotion